STOCKNO.DE
Institutional ownership intelligence

FMCQF Institutional Ownership

Fresenius Medical Care AG

Latest stored close $40.81 as of Oct 9, 2026 View live quote ↗

☆ Add to watchlist
STOCKNODE Outlook

Neutral

57/100 1 tracked · 0 comparable
Latest filing Jul 28, 2026
Positive breadth 1 positive · 0 negative
Recent close $40.81
Research confidence Limited
Institutional Research 56/100 · 0 accumulating · 0 reducing / exited
Ownership history

Reported ownership % history

Latest filing Jul 28, 2026

See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.

Locked preview
Unlock the reported ownership timeline Unlock full research
Accumulating0
Newly reported1
Reducing / exited 0
52-week position —
Institutional Intelligence

Why STOCKNODE says Neutral

What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.

3 evidence layers available
STOCKNODE Outlook
Neutral 57/100
Confidence:Limited
Why this signal
  • 0 tracked institutions accumulating versus 0 reducing/exited.
  • Comparable SEC fundamentals are improving.
STOCKNODE Outlook is a quantitative research signal based on reported public data, not personalized investment advice.
Institutional
56/100
Fundamentals
61/100

Cross-institution positioning

Jul 28, 2026

Mixed positioning. No institution has two comparable Schedule 13 observations yet.

Source: Schedule 13 research

SEC fundamentals

Feb 24, 2026

Revenue +1.5% YoY; Net income +60.8% YoY. Periods are compared only when the SEC facts are aligned and comparable.

Source: SEC Company Facts

Price context

Sep 15, 2026

Recent close is 15% through its reported 52-week range; -9.8% over one year.

Source: Stored historical price series
Latest filing decision brief Investor / Pro

Research the latest Initial Schedule 13G from BlackRock.

Filed Jul 28, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.

Premium research values are withheld until unlocked.

Supporting institutional evidence

Institutional Evidence

The research summary above gives the current read. This section shows the dated holder-level evidence behind it.

Latest reported position changes

Investor / Pro detail

See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.

Newest filing Jul 28, 2026
BlackRock Filed Jul 28, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis. No premium position values are sent in this locked preview.
Unlock full research

Reported direction breadth by as-of date

Locked preview

Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.

Unlock actual accumulation vs. reduction breadth across reported position dates. View plans

Institution comparison

Investor / Pro detail

Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.

BlackRock Filed Jul 28, 2026
Unlock the evidence behind the score

Know who changed position, by how much, and when the SEC learned about it.

Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.

✓ Actual share and ownership changes ✓ Position as-of date vs. SEC filed date ✓ Deterministic direction basis ✓ Full evidence on every eligible stock
SEC-reported company fundamentals

Fundamentals

Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.

Latest filing used Feb 24, 2026
Revenue 19.6B EUR FY 2025 +1.5% YoY 20-F filed Feb 24, 2026
Net income 1.2B EUR FY 2025 +60.8% YoY 20-F filed Feb 24, 2026
Diluted EPS 3 EUR/shares FY 2025 +83.6% YoY 20-F filed Feb 24, 2026
Operating cash flow 2.7B EUR FY 2025 +12.4% YoY 20-F filed Feb 24, 2026
Cash & equivalents 1.6B EUR As of Dec 31, 2025 +35.5% YoY 20-F filed Feb 24, 2026
Assets 31.0B EUR As of Dec 31, 2025 -7.6% YoY 20-F filed Feb 24, 2026
Liabilities 16.7B EUR As of Dec 31, 2025 -6.1% YoY 20-F filed Feb 24, 2026
Stockholders’ equity 14.3B EUR As of Dec 31, 2025 -9.4% YoY 20-F filed Feb 24, 2026
Shares outstanding 279.3M As of Dec 31, 2025 -4.8% YoY 20-F filed Feb 24, 2026
View recent revenue trend

Annual

PeriodRevenueYoY
Ended Dec 31, 2025 19.6B EUR +1.5%
Ended Dec 31, 2024 19.3B EUR -0.6%
Ended Dec 31, 2023 19.5B EUR +0.3%
Ended Dec 31, 2022 19.4B EUR +10.1%
Current market context

Price performance

Dated price context from the historical market series already collected for this security.

As of Sep 15, 2026
Recent stored close $44.12 View live quote ↗
52-week low $42.00 May 11, 2026
52-week high $56.24 Oct 27, 2025
Below 52-week high 21.6%
1W return -14.2%
1M return -14.2%
3M return -2.3%
6M return -10.3%
YTD return -5.2%
1Y return -9.8%
30-day volatility 44.5%
90-day volatility 33.4%
1Y max drawdown -25.3%

Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.

How to read Schedule 13 ownership changes

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.

Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.

Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.

Beneficial ownership filing history

Showing 1 of 1 filing(s)
View beneficial ownership filing evidence
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
BlackRock CIK0002012383 Jun 30, 2026 observed Jul 28, 2026 filed · 28d Initial Schedule 13G Initial Schedule 13G 13.4M 12.00% $45.17 $48.85 $40.81
Explore more institutional activity

Related research

Compare FMCQF with other securities showing similar institutional activity or recent accumulation across several tracked institutions.